RE:RE:RE:RE:RE:RE:RE:RE:Some comments from FredThis was something know at the beginning. PLI contribution was the transfert of rights to use the technology. And more Nantpro will fund the development, more it will be dilutive for PLI.
But the most important thing, is not that PLI might end up with 10% or not, but it's the fact that PLI will have the rights to commercialise the final product outside North America, as Nantpro have only the north american rights.
So, if it's something of great value, such as facor VIII or IGIV, this could be very interesting for PLI.